Literature DB >> 2008269

Risk factors for metastases in patients with retinoblastoma.

E P Messmer1, T Heinrich, W Höpping, E de Sutter, W Havers, W Sauerwein.   

Abstract

The study is based upon a review of data from 583 consecutive patients with retinoblastoma over the years 1956 to 1986. Mean follow-up was 8 years, and median was 5.5 years. In 41 patients, metastases developed within 5 years. The influence of clinical and histopathologic risk factors on the occurrence of metastases was first analyzed by univariate tests. Significant variables were then reevaluated using the Cox proportional hazards method. Four factors were found to be independently associated with the development of metastases: optic nerve invasion with and without involvement of the resection line, choroidal invasion and enucleation of an affected eye more than 120 days after initial diagnosis. The 5-year metastatic risks associated with these factors were 67%, 13%, 8%, and 4%, respectively. The relative risk estimate, calculated from the Cox model, was used for a score classification with groups of low, medium, and high metastatic risk. The 5-year incidence of metastases was 4%, 43%, and 68%, respectively.

Entities:  

Mesh:

Year:  1991        PMID: 2008269     DOI: 10.1016/s0161-6420(91)32325-x

Source DB:  PubMed          Journal:  Ophthalmology        ISSN: 0161-6420            Impact factor:   12.079


  29 in total

1.  Retinoblastoma - MR appearance using a surface coil in comparison with histopathological results.

Authors:  Arne-Jörn Lemke; Iris Kazi; Ulrike Mergner; Paul Ivan Foerster; Heinrich Heimann; Nikolaos Bechrakis; Andreas Schüler; Marie-Isabell Senfft von Pilsach; Michael Foerster; Roland Felix; Norbert Hosten
Journal:  Eur Radiol       Date:  2006-04-25       Impact factor: 5.315

Review 2.  Survival in extra-orbital metastatic retinoblastoma:treatment results.

Authors:  Carlos A Leal-Leal; Roberto Rivera-Luna; Martha Flores-Rojo; Juan C Juárez-Echenique; Juan C Ordaz; Jorge Amador-Zarco
Journal:  Clin Transl Oncol       Date:  2006-01       Impact factor: 3.405

Review 3.  Chemotherapy for retinoblastoma: a current topic.

Authors:  P T Finger; G Czechonska; H Demirci; A Rausen
Journal:  Drugs       Date:  1999-12       Impact factor: 9.546

4.  Retinoblastoma. Fifty years of progress. The LXXI Edward Jackson Memorial Lecture.

Authors:  Hans E Grossniklaus
Journal:  Am J Ophthalmol       Date:  2014-07-24       Impact factor: 5.258

5.  High-resolution MRI using orbit surface coils for the evaluation of metastatic risk factors in 143 children with retinoblastoma: Part 1: MRI vs. histopathology.

Authors:  Selma Sirin; Marc Schlamann; Klaus A Metz; Norbert Bornfeld; Bernd Schweiger; Markus Holdt; Petra Temming; Michael M Schuendeln; Sophia L Goericke
Journal:  Neuroradiology       Date:  2015-06-04       Impact factor: 2.804

Review 6.  Retinoblastoma: an overview.

Authors:  Anish Ray; Dan S Gombos; Tribhawan S Vats
Journal:  Indian J Pediatr       Date:  2012-03-16       Impact factor: 1.967

7.  Study of Unilateral Retinoblastoma With and Without Histopathologic High-Risk Features and the Role of Adjuvant Chemotherapy: A Children's Oncology Group Study.

Authors:  Patricia Chévez-Barrios; Ralph C Eagle; Mark Krailo; Jin Piao; Daniel M Albert; Yun Gao; Geeta Vemuganti; Mohammad Javed Ali; Vikas Khetan; Santosh G Honavar; Joan O'Brien; Ann-Marie Leahey; Katherine Matthay; Anna Meadows; Murali Chintagumpala
Journal:  J Clin Oncol       Date:  2019-09-20       Impact factor: 44.544

8.  Diagnostic performance of MRI of post-laminar optic nerve invasion detection in retinoblastoma: A systematic review and meta-analysis.

Authors:  Se Jin Cho; Jae Hyoung Kim; Sung Hyun Baik; Leonard Sunwoo; Yun Jung Bae; Byung Se Choi
Journal:  Neuroradiology       Date:  2020-08-31       Impact factor: 2.804

9.  Retinoblastoma patients with high risk ocular pathological features: who needs adjuvant therapy?

Authors:  G L Chantada; I J Dunkel; M T G de Dávila; D H Abramson
Journal:  Br J Ophthalmol       Date:  2004-08       Impact factor: 4.638

10.  Choroidal invasion of retinoblastoma: metastatic potential and clinical risk factors.

Authors:  C L Shields; J A Shields; K A Baez; J Cater; P V De Potter
Journal:  Br J Ophthalmol       Date:  1993-09       Impact factor: 4.638

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.